Lilly direct-selling Zepbound at $499/mo — compare with 11 other programs

Zepbound vs Rybelsus

Editorial comparison of Zepbound (tirzepatide) and Rybelsus (semaglutide (oral)). Same drug class context, trial-anchored data, no marketing claims.

Reviewed by the glpzoom Editorial Team against primary clinical sources — FDA labeling, peer-reviewed trials, and specialty-society guidelines.
Content current as of June 2026; updated when guidance or availability changes.

Side-by-side

DimensionZepboundRybelsus
Generic nametirzepatidesemaglutide (oral)
ManufacturerEli LillyNovo Nordisk
FDA approved20232019
MechanismTirzepatide is a dual incretin agonist: it hits both the GLP-1 receptor (like semaglutide) and the GIP receptor (which semaglutide doesn't).GLP-1 receptor agonist, identical mechanism to injectable semaglutide.
DosingTitrated 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg, every 4 weeks. Maintenance 5-15mg weekly depending on tolerability and target weight.Once daily on an empty stomach with ≤4 oz water, 30 minutes before food/drink/other meds. Titrated 3mg → 7mg → 14mg.
CostList price ~$1,000-1,300/month.List ~$900-1,000/month. Diabetes coverage generally better than weight-loss coverage. NovoCare self-pay options available for eligible patients.
Pivotal trial result20.9% mean body-weight reduction at 72 weeks (15 mg dose)

Full Zepbound review →

Dual GLP-1/GIP agonist for weight management. ~20% body weight loss in trials — strongest weight-loss drug currently available.

Full Rybelsus review →

Oral semaglutide tablet for type 2 diabetes. Same molecule as Ozempic/Wegovy in pill form, with strict fasting-and-water dosing rules.

Frequently asked

Is Zepbound or Rybelsus more effective?+

In their pivotal trials, Zepbound reported 20.9% mean body-weight reduction at 72 weeks (15 mg dose), while Rybelsus reported no headline result on file. Head-to-head results vary by patient profile, dose tolerated, and adherence — these trial numbers describe averages, not what every individual experiences.

How do Zepbound and Rybelsus compare on cost?+

Zepbound: List price ~$1,000-1,300/month. Lilly's patient assistance program (LillyDirect Self-Pay) offers $399-549/month for self-pay patients depending on dose. Insurance coverage similar pattern to Wegovy. Rybelsus: List ~$900-1,000/month. Diabetes coverage generally better than weight-loss coverage. NovoCare self-pay options available for eligible patients. Real out-of-pocket depends on insurance formulary tier, manufacturer savings programs, and whether a direct-pay channel is available.

Can I switch from Zepbound to Rybelsus?+

Switching between brand-name treatments in the same drug class is common, but the conversion is not always 1:1. Discuss the switch with your prescriber — they'll usually re-titrate dosing rather than substitute equivalent strengths directly.

Are Zepbound and Rybelsus the same drug?+

No. Zepbound (tirzepatide) and Rybelsus (semaglutide (oral)) are distinct medications from Eli Lilly and Novo Nordisk respectively. They may share a drug class or mechanism but differ in active ingredient, dosing, and approved use.

We may earn a commission when you click links to partners. Affiliate disclosure.